Background: Describing severity of mitral regurgitation (MR) in dogs with degenerative mitral
| INTRODUCTION
Degenerative mitral valve disease (DMVD) in the dog is characterized by age-related morphological and structural changes in the valve that lead to mitral regurgitation (MR). 1 The MR caused by DMVD has been called "unrelentingly although variably progressive" 2 and as such, stratification of MR severity in both humans and dogs with DMVD is a subject of considerable clinical interest. 3 Specifically, determination of which dogs with preclinical or asymptomatic MR will develop cardiomegaly is an important clinical question, particularly in light of the fact that treatment in this cohort improves outcome. 4 A substantial proportion of both dogs [5] [6] [7] [8] and humans 9, 10 remain in the preclinical stage of DMVD for extended periods of time whereas others experience progressive disease and clinical development of congestive heart failure (CHF). To date, little data examining risk of cardiomegaly in dogs with early preclinical DMVD exist.
In humans with DMVD, echocardiography is widely used to assess severity of MR, 11 however, in contrast to common practice in veterinary species, relatively little weight is given to 1-dimensional chamber sizes such as left atrial or left ventricular (LV) diameter. Rather, severity of MR is routinely assessed by multidimensional indices such as the mitral effective regurgitant orifice area (EROA) and regurgitant fraction (RF) that take into account not only diastolic heart size, but importantly forward and mitral flow and systolic function. [11] [12] [13] Mitral EROA corresponds to the cross-sectional area (CSA) of the narrowest region (ie, the vena contracta) of MR flow (Q MR ) as it moves from left ventricle to atrium during LV systole, whereas mitral RF is the percentage of total LV stroke volume (TOT SV) that regurgitates back through the mitral valve. In humans with DMVD, EROA ≥0.40 cm 2 , regurgitant volume ≥60 mL, and RF ≥50% are established criteria for severe preclinical disease and increased risk for future clinical signs. 12 We hypothesized that EROA, RF, and ratio of mitral regurgitant to aortic flow (Q MR :Q Ao ) would provide more information regarding MR severity than 1-dimensional measures in dogs with preclinical DMVD.
Previous studies have examined mitral EROA and RF in dogs, [14] [15] [16] [17] [18] [19] however, adoption into routine clinical practice is hindered by the complexity of the echocardiographic procedures used to perform the necessary measurements and calculations. Thus, we specifically sought to evaluate relatively simple echocardiographic methods to derive EROA, RF, and Q MR :Q Ao and to describe their relationships with indices of left heart enlargement.
| MATERIALS AND METHODS
The study was a single-site prospective observational cohort study. The study utilized a convenience sample and all dogs recruited into the study were already scheduled to undergo 2D, M-mode, and Doppler echocar- The utility of indices of MR severity to predict presence of clinically relevant heart enlargement (ie, inclusion in Group 2) was evaluated by construction of receiver-operating characteristic (ROC) curves and calculation of various diagnostic metrics as follows. First, the overall ability of each variable to predict patient group was assessed by the area under the curve (AUC). The AUC represents the probability that a randomly selected subject with the condition of interest has a test result indicating greater suspicion of disease than a randomly selected individual without the condition. 28 We defined AUC values >0.85 as indicative of a clinically useful test, 29 whereas an AUC value of 0.5 indicates the test is no better than chance. Second, sensitivity, specificity, positive likelihood ratio (ie, ratio of a positive test in the affected vs ratio of positive test in the unaffected) and negative likelihood ratio (ie, ratio of a negative test in the affected vs the ratio of a negative test in the unaffected) for various variable values were calculated. The diagnostic odds ratio (OR), which is the ratio of the odds of a positive test in the affected over the odds of the positive test in the unaffected, was calculated for various variable values. 30 The probabilistic method was used to calculate OR in instances where any cell contained a zero value. 31 Finally, the AUC values related to RF, EROA, and Q MR :Q Ao that were derived from the prolate ellipse method were compared to AUC values that were derived from the mitral inflow method. 32 Significance was defined as P < .05. Data are reported as mean 
| RESULTS
Echocardiography and blood pressure measurement were performed on 59 dogs. The mean difference in RF values was −1% (95% CI, −6 to 4%) and this value was not significantly different than a value of 0 (P = .56).
The relationships between LA:Ao and LVIDdN and RF, EROA:
BSA, and Q MR :Q Ao were nonlinear and well described by the predicted regression formulae ( Figure 1 Based on the ROC results, the OR for each of the 3 indices of MR severity associated with having LA:Ao ≥1.6 and LVIDdN ≥1.7 were as follows:
for RF ≥50%, odds were 108.5 (95% CI, 6.0-1959.7, P = .002) times higher vs RF < 50%; for EROA:BSA ≥0.347, odds were 100.0 (95% CI, 11.2-894.7, P < .0001) times higher vs EROA:BSA < 0.347; for Q MR :Q Ao was ≥0.79, odds were 33.3 (95% CI, 6.4-174.1, P < .0001) times higher vs Q MR :Q Ao < 0.79. There was good agreement between results using the prolate ellipse method as compared to the mitral inflow method (see Supplemental Materials).
| DISCUSSION
The results of this study demonstrate that multidimensional echocardiographic indices, namely RF, EROA, and Q MR :Q Ao , vary in an expected mathematical manner with 1-dimensional measurements of left heart size, and that these indices differentiate severity of MR in dogs with preclinical DMVD in a way that 1-dimensional measurements do not.
These findings make sense for a variety of reasons. First, the mathematical relationship between volume and length is based on the cube of the length, and the expected curvilinear function contributes to the relationships found in Figure 1 . With respect to the expected relationship between mitral RF and 1-dimensional heart size, the specific presence of the independent variable (ie, RF) in the denominator creates an initial "flat" portion of the curve, wherein LA:Ao and LVIDdN show relatively little change as MR severity increases, followed by a more steep possible, yet results of the current study clearly demonstrate that RF is able to differentiate a wide range MR severity. Our study reveals the odds of having LA:Ao ≥1.6 and LVEDdN ≥1.7 were 108 times higher for dogs with RF ≥50% vs those with RF <50%. The implication of our results is that RF might help determine which dogs are at highest risk for future left heart enlargement, and a longitudinal study to test this hypothesis is warranted. It is tempting to speculate that as RF increases toward 50% in dogs with stage B1 disease, the risk for cardiomegaly substantially increases. This is of particular interest because of the high variability associated with rate of progression. 5 Our data indicate that a simple method for deriving RF in dogs with preclinical DMVD helps discriminate MR severity. These findings are consistent with studies of asymptomatic MR in human patients wherein RF represents an important benchmarking tool with respect to disease severity and prognosis. 36 Guidelines developed by the American Heart Association and American College of Cardiology for management of valvular heart disease in asymptomatic MR patients specifically consider RF ≥50% as a major risk factor for development of clinical signs or need for valve surgery, especially when accompanied by declining myocardial function. 12 Another marker of MR severity is EROA. In the current study, the odds of having LA:Ao ≥1.6 and LVEDdN ≥1. Figure 1A in the current study, and it is tempting to speculate that the previously published plot might have been better fit using a nonlinear function.
The results of the current study offer clues as to why a RF of 50%
is an important threshold. The 3 main indices of MR investigated by 40 Once cardiomegaly ensues, it is well accepted that "MR begets MR" by causing ever increasing amounts of annular dilation, stress on the valve apparatus, and worsening of existing MR. 12 Thus, the importance of RF ≥50% is likely related to the start of this vicious cycle resulting in an increase in the rate of heart enlargement and disease severity. 36 Direct measurement of the anatomic or EROA is another quantitative method and can be performed using 2D, 3D, or color flow Doppler echocardiography, but is limited by high interobserver and intraobserver variability. 43 There are several important potential limitations to this study.
The study was observational in nature and longitudinal studies are needed to relate RF with the timeline of disease progression. Longitudinal studies are difficult and heavily resource-consuming, and in humans, much of the natural history of asymptomatic MR is derived from observational data, 3 however, the full value of the proposed indices will only be known from such studies. For instance, it is tempting to speculate that multidimensional indices of MR severity in dogs with preclinical DMVD will predict risk of future cardiac enlargement, onset of clinical signs, and prognosis in a way that current 1-dimensional measurements are unable to. In humans with DMVD, no single index best quantifies MR severity, and at least 6 different anatomic and qualitative and quantitative echocardiographic findings are integrated to best assess MR severity. 11, 49, 50 Future studies in dogs might investigate which combination of measures provides the greatest information. As previously mentioned, the volumetric method used in this study was based on assumptions of LV shape that are not necessary In the current study, comparison of RF, EROA, and Q MR :Q Ao to a gold standard was not performed, however, the proposed utility of these parameters (ie, as repeated measures in an individual) is less reliant on validation against an external reference standard and more reliant on internal consistency. Our study involved a single referral center and results should be confirmed in a larger and more geographically diverse population; however, our study cohort included a typical older and small-breed population of dogs with DMVD. The patient sample size was relatively small and confidence intervals around OR values were wide, however, the magnitude of effect was substantial and clinically relevant across the range of estimates. Finally, measurement of MR VOL by the technique used in the current study is invalid or difficult to perform in dogs with substantial aortic insufficiency or arrhythmias, such as atrial fibrillation.
In conclusion, measurement of RF, EROA, and Q MR :Q Ao in dogs with preclinical DMVD is supported by the mathematical and pathophysiological aspects of their relationship with MR and differentiates severity of DMVD in a manner that 1-dimensional measurements of chamber diameter do not.
